Vaccines for the World
Contributor: Miss Chanice Henry
Posted: 05/04/2016
Cold Chain Logo
China’s State Council has passed an amendment on vaccine regulations just weeks after the launch of an investigation into incorrectly handled vaccines took place, in ‘a case that shook the country’. The amendment, which impacts multiple articles within Regulations for the Circulation and Inoculation of Vaccines, was passed on April 24th.Cold c Full Article »
Posted: 08/05/2014
Cool Chain 2015 - Where the Industry Meets to Shape its Future
With over 500 participants from hundreds of different pharmaceutical manufacturers, leading solution providers and cold chain logistics experts, Cool Chain & Temperature Controlled Logistics Europe 2015 is truly an event not-to-be-missed! Full Video »
Contributor: Andrea Charles
Posted: 10/23/2011
cc_podcasts
The 2 million vaccine preventable deaths do not occur for lack of vaccines, but because of inadequate distribution. In this interview Harvey Rubin, Director of Strategic Threat Analysis and Response at the University of Pennsylvania, speaks to Andrea Charles from Pharma IQ, about the Our Energy for Health Project whose proposal is to use the Full Podcast »
Contributor: Tony Hitchcock
Posted: 05/16/2016
Tony Hitchcock
Earlier this year I was fortunate enough to attend the Disposable Solutions meeting in Munich. A common theme of discussions was the on-going debates around the issues of leachable and extractables and the associated testing standards. This is a topic that has been debated for as long as I have been attending meetings on single use systems, and still seems to be a long way from a consensus between various end users and manufacturing bodies on how to address this issue. Full Column »
Contributor: Pharma IQ
Posted: 05/26/2016
Tampering
Counterfeit pharmaceuticals can cause a lot of harm – drug recalls, loss of public confidence, law suits, and risks to patient safety. In the combat against malicious tampering, anti-counterfeiting technology aims to prevent the emergence of counterfeit drugs by creating hurdles to deter by making the task of cloning a drug too complex and expensive. Full Whitepaper »